Central Nervous System Clinical Trials in Beijing, Beijing Municipality
15 recruitingBeijing, Beijing Municipality, China
Showing 1–15 of 15 trials
Recruiting
Phase 2
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Primary Central Nervous System Lymphoma (PCNSL)
Beijing Tongren Hospital43 enrolled1 locationNCT07523737
Recruiting
Not Applicable
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
Central Nervous System Infections
RenJi Hospital310 enrolled35 locationsNCT06358209
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.800 enrolled34 locationsNCT07143045
Recruiting
Phase 3
A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Shanghai Shengdi Pharmaceutical Co., Ltd250 enrolled2 locationsNCT07275814
Recruiting
Phase 1Phase 2
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Central Nervous System Lymphoma
Tong Chen, MD30 enrolled5 locationsNCT05698147
Recruiting
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Hemangioma, Cavernous, Central Nervous System
Beijing Tiantan Hospital1,200 enrolled1 locationNCT06214767
Recruiting
Not Applicable
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Acute Disseminated EncephalomyelitisMS (Multiple Sclerosis)Transcranial Alternating Current Stimulation+2 more
Xuanwu Hospital, Beijing128 enrolled1 locationNCT07087873
Recruiting
Phase 1Phase 2
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
Central Nervous System Tumors
Binhui Biopharmaceutical Co., Ltd.28 enrolled1 locationNCT05235074
Recruiting
Not Applicable
Effectiveness of Personalized Alternating Current Stimulation for Treating Emotional Disorders in CNS Demyelination Patients
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing65 enrolled1 locationNCT06933537
Recruiting
China National Registry of Neuro-Inflammatory Diseases
Multiple SclerosisClinically Isolated SyndromeAcute Disseminated Encephalomyelitis+4 more
Beijing Tiantan Hospital10,000 enrolled1 locationNCT05154370
Recruiting
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Germ Cell TumorGliomaBrain Tumor, Pediatric+3 more
Beijing Tiantan Hospital400 enrolled1 locationNCT05672043
Recruiting
Phase 2
Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
Primary Central Nervous System Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences36 enrolled1 locationNCT05549284
Recruiting
Phase 2
Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL
Primary Central Nervous System Lymphoma
Peking Union Medical College Hospital50 enrolled3 locationsNCT05390749
Recruiting
Phase 2Phase 3
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing100 enrolled1 locationNCT02657785
Recruiting
Phase 2Phase 3
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing100 enrolled1 locationNCT02836158